Marel hf.
Marel hf. will publish its 2020 consolidated financial statements after market closing on 3 February 2021.
Earnings conference call and webcast
On Thursday 4 February 2021, at 8:30 am GMT (9:30 am CET), Marel will host a virtual investor meeting where CEO Arni Oddur Thordarson and CFO Linda Jonsdottir will give an overview of the financial results and operational highlights in the fourth quarter and for the full year.
The meeting will be webcast live on www.marel.com/webcast and a recording will be available after the meeting on www.marel.com/ir .
Members of the investment community can also join the meeting through a conference call by dialing:
- IS: +354 800 7520
- NL: +31 10 712 9162
- UK: +44 33 3300 9262
- US: +1 833 526 8384
Financial calendar
- AGM – 17 March 2021
- Q1 2021 – 28 April 2021
- Q2 2021 – 21 July 2021
- Q3 2021 – 20 October 2021
- Q4 2021 – 2 February 2022
Investor relations
For further information, please contact Marel Investor Relations via email ir@marel.com or tel. +354 563 8001.
About Marel
Marel (NASDAQ: MAREL; AEX: MAREL) is a leading global provider of advanced food processing equipment, systems, software and services to the poultry, meat and fish industries. Following the closing of the TREIF acquisition on 8 October 2020, Marel has around 7,000 employees in over 30 countries. In 2019, Marel delivered EUR 1.3 billion in revenues, and invests around 6% of revenues in innovation annually. By continuously transforming food processing, Marel enables its customers to increase yield and throughput, ensure food safety and improve sustainability in food production. Marel was listed on NASDAQ Iceland in 1992 and dual-listed on Euronext Amsterdam in June 2019.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom